Chemfab Alkalis Ltd

Chemfab Alkalis Ltd has announced that its Board of Directors will convene on July 29, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The trading window for the company's shares will remain closed from July 1, 2026, until 48 hours after the declaration of these financial results, extending until July 31, 2026, in compliance with SEBI regulations.

Chemfab Alkalis Ltd has announced the closure of its trading window for all directors, designated employees, insiders, and their relatives. The window will be closed from July 1, 2026, until 48 hours after the announcement of the Un-Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The specific date for the Board Meeting to consider these financial results will be communicated separately.

Chemfab Alkalis Ltd has invested ₹14,90,99,985.30 in Zenataris Renewable Energy Private Limited on May 19, 2026, to subscribe to 3.35% equity shares at ₹66.10 each under a group captive mechanism. This investment aims to lower tariffs and achieve cost savings. Zenataris Renewable Energy, incorporated on October 8, 2018, focuses on developing and managing solar and wind power assets.

Chemfab Alkalis Ltd's board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A final dividend of ₹1.25 per share was recommended for shareholder approval. M/s. Madhavan, Mohan & Associates were re-appointed as Cost Auditors, and M/s. Brahmayya & Co, Chartered Accountants, were appointed as Internal Auditors for FY 2026-2027.

Chemfab Alkalis Ltd's board approved recommending a dividend of ₹1.25 per equity share to shareholders during its meeting on May 13, 2026. The board also approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Additionally, the reappointment of M/s. Madhavan, Mohan & Associates as cost auditor and the appointment of M/s. Brahmayya & Co as internal auditors for FY 2026-2027 were approved.

Chemfab Alkalis Ltd's board meeting on May 13, 2026, approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of ₹1.25 per share for shareholder approval at the upcoming Annual General Meeting. Additionally, M/s. Madhavan, Mohan & Associates were reappointed as cost auditors, and M/s. Brahmayya & Co were appointed as internal auditors for the financial year 2026-2027.

Chemfab Alkalis Ltd has scheduled a Board of Directors meeting on May 13, 2026, to consider and approve the audited standalone and consolidated financial statements for the quarter and financial year ended March 31, 2026. The board will also consider the declaration of a dividend, subject to shareholder approval. The trading window for dealing in the company's shares remains closed from April 1, 2026, until 48 hours after the declaration of the audited financial results, effective until May 15, 2026.

Chemfab Alkalis Ltd has announced the closure of the trading window for all Directors, Designated Employees, other insiders of the Company and their relatives from 1st April 2026 till the expiry of 48 hours after the announcement of the Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March 2026. This is in line with the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's 'Code of Conduct for Prevention of Insider Trading'. The date of the Board Meeting for considering the Audited Standalone and Consolidated Financial Results for the Quarter and Year ended 31st March 2026 will be intimated separately.

Chemfab Alkalis Ltd. has announced that its Board of Directors will meet on January 28, 2026, to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025. In accordance with the Company's Code of Prevention of Insider Trading and SEBI (Prohibition of Insider Trading) Regulations, 2015, the 'Trading Window' for dealing in the company's shares by the Directors, Designated Employees, other insiders, and their relatives will be closed from January 1, 2026, till the completion of 48 hours after the declaration of the financial results, i.e., effective from January 1, 2026, till January 30, 2026.

Chemfab Alkalis Ltd has successfully commissioned the latest generation INEOS Electrolyser, replacing the existing 30-year-old 2nd-Generation UHDE Electrolyser and associated equipment. This replacement is expected to improve overall efficiency and optimize costs, leading to an enhanced operating rate with better reliability. Power savings are also anticipated from Q4 of the Financial Year 2025-26. The consent capacity remains at 180 tonnes per day, with a capex of approximately Rs. 57 Crs. funded through internal accruals.